Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 3Unknown 2Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2CNS 2Sarcoma 1

Conditions

Carcinoma, Non-Small-Cell Lung 72Lung Neoplasms 9Adenocarcinoma of Lung 7Brain Neoplasms 5Non-squamous Non-small Cell Lung Cancer 4NSCLC 4Adenocarcinoma 4Mesothelioma, Malignant 3Colorectal Neoplasms 3Nonsquamous Non-Small Cell Lung Cancer 2Non-squamous Cell Non-Small Cell Lung Cancer 2Neoplasms 2Meningeal Carcinomatosis 2Lymphoma 2Glioma 2Central Nervous System Neoplasms 2Urinary Bladder Neoplasms 1Ureteral Neoplasms 1Untreated Advanced Non-Small Cell Lung Cancer 1Unresectable Stage III NSCLC 1Thyroid Neoplasms 1Thyroid Carcinoma, Anaplastic 1Thoracic Neoplasms 1Stomach Neoplasms 1Stereotactic Radiotherapy; Evoximab (AK112); New Adjuvant Therapy for Non-small Cell Lung Cancer 1Staging IV NSCLC 1Squamous Cell Lung Cancer 1Squamous Cell Carcinoma of Head and Neck 1Solid Tumor 1Respiratory Tract Neoplasms 1

Interventions

Cyclophosphamide 37Etoposide 25Vincristine 24Cytarabine 21Doxorubicin 19Rituximab 17Radiotherapy 17Peripheral Blood Stem Cell Transplantation 16Melphalan 16Prednisolone 14Methotrexate 14Filgrastim 13fludarabine phosphate 11Prednisone 11Dexamethasone 11Carmustine 9Bleomycin 9pegylated granulocyte colony-stimulating factor 8Cyclosporine 8Busulfan 8fludarabine 7Ifosfamide 7Cisplatin 7sargramostim 6Vinblastine 6Mitoxantrone 6Methylprednisolone 6Gemcitabine 6Chlorambucil 6Antilymphocyte Serum 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Lymphoma × Pemetrexed × Clear all
NCT00276783 2020-03-05

Pemetrexed Disodium in Treating Patients With Recurrent Malignant Gliomas, Primary CNS Lymphoma, or Brain Metastases

Northwestern University

Phase 2 Unknown
31 enrolled
CNSLymphoidSarcoma

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Lymphoma, Neoplasm Metastasis, Oligodendroglioma, Central Nervous System Neoplasms, Gliosarcoma

NCT01985451 2013-11-15

Pemetrexed and Temozolomide in Treating Patients With Relapsed Primary Central Nervous System Lymphoma (PCNSL)

Shandong Cancer Hospital and Institute

Phase 2 Unknown
15 enrolled
CNSLymphoid

Lymphoma, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡